The Effects of Ondansetron on Myocardial Repolarization in Children Receiving Chemotherapy

Trial Profile

The Effects of Ondansetron on Myocardial Repolarization in Children Receiving Chemotherapy

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 07 Oct 2013

At a glance

  • Drugs Ondansetron (Primary)
  • Indications Chemotherapy-induced nausea and vomiting
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Oct 2013 Planned End Date changed from 1 May 2014 to 31 Oct 2013 as reported by ClinicalTrials.gov.
    • 01 Oct 2013 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 24 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top